Surveillance of cirrhotic patients using the protein induced by vitamin K absence or antagonist II (PIVKA-II)

被引：2
|
作者：
Nicolosi, Aurora [1 ]
Pellicano, Rinaldo [2 ]
Caviglia, Gian Paolo [1 ]
机构：
[1] Univ Turin, Dept Med Sci, I-10100 Turin, Italy
[2] Molinette Mauriziano Hosp, Unit Gastroenterol, Citta Salute & Sci, Turin, Italy
来源：
MINERVA MEDICA | 2022年 / 113卷 / 01期
关键词：
HEPATOCELLULAR-CARCINOMA; AFP-L3;
D O I：
10.23736/S0026-4806.21.07952-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：106 / 108
页数：3
相关论文
共 50 条
  • [21] THE EFFECTS OF PLASMA VITAMIN-K ON PIVKA-II SYNTHESIS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    SAKON, M
    MONDEN, M
    GOTOH, M
    KANAI, T
    UMESHITA, K
    MORI, T
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 366 - 366
  • [22] Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma
    Jang, Tyng-Yuan
    LIVER INTERNATIONAL, 2023, 43 (02) : 518 - 519
  • [23] VITAMIN-K-DEFICIENCY IN NEWBORNS - CLINICAL RELEVANCE OF PIVKA-II DETERMINATIONS
    VONKRIES, R
    BECKER, A
    GOBEL, U
    HAEMOSTASIS, 1986, 16 : 85 - 86
  • [24] Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
    Dong, Libin
    Qiu, Xun
    Gao, Fengqiang
    Wang, Kai
    Xu, Xiao
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (06):
  • [25] Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma
    Ajisaka, H
    Shimizu, K
    Miwa, K
    JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (02) : 89 - 93
  • [26] Can Proteins Induced by Vitamin K absence - PIVKA II - detect subclinical vitamin K deficit in major
    Schott, U.
    Anveden, P.
    Strandberg, K.
    Flisberg, P.
    Engstrom, M.
    Hillarp, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 404 - 405
  • [27] Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients
    El Gawad, Iman A. Abd
    Mossallam, Ghada I.
    Radwan, Noha H.
    Elzawahry, Heba M.
    Elhifnawy, Niveen M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (02) : 79 - 85
  • [28] Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels
    Syriha, Antonia
    Pantzios, Spyridon
    Mandilara, Dionysia
    Galanis, Petros
    Stathopoulou, Ioanna
    Barla, Georgia
    Elefsiniotis, Ioannis
    CANCER MEDICINE, 2024, 13 (03):
  • [29] Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)
    Caviglia, G. P.
    Abate, M. L.
    Ciruolo, M.
    Carucci, P.
    Olivero, A.
    Rolle, E.
    Rosso, C.
    Younes, R.
    Ciancio, A.
    Smedile, A.
    Saracco, G. M.
    Bugianesi, E.
    Gaia, S.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E54 - E54
  • [30] PLASMA PIVKA-II LEVELS IN EPILEPTIC PATIENTS
    ORIGUCHI, Y
    MOTOHARA, K
    ENDO, F
    MATSUDA, I
    BRAIN & DEVELOPMENT, 1990, 12 (04): : 451 - 451
12345